COMT and Parkinson disease: While these enzymes areunderstudied in the context of PD and VP, the link of UDPglucuronosyltransferase1A9 genotype to adverse reactionsto catechol-O-methyltransferase inhibitors in PD patientswas reported (Ferrari et al., 2012).